IQN CEO Dr Syrmalis stated in relation to the transaction "A ground breaking, innovative business, iQnovate Ltd, joining forces with a most inspiring and creative media house, Emedia, Creating a partnership that communicates life sciences in a coherent manner across society. The biotech industry is evolving so rapidly that organic growth alone, will not suffice for a business to lead its sector, hence we will be focusing on growth through acquisitions."
About iQ3Corp Ltd:
iQ3Corp Ltd (ASX:IQ3) is the world's first specialised life science corporate financial advisory and asset management firm.
iQ3Corp capitalises on its relationship with The iQ Group Global Companies and other industry participants such as academic institutions, financial market participants and other Life Science industry bodies, to provide a turnkey solution for capital raising from corporate inception to the capital markets.
iQ3 provides advice to life science companies on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and corporate finance, as well as asset management services to corporations, partnerships, institutions, governments, and individuals.
Source:
iQ3Corp Ltd
Contact:
iQ3Corp Ltd T: +61 2 8239 5400 E: investor.relations@iq3corp.com WWW: www.iq3corp.com